Register today for the 2023 North American Viral Hepatitis Elimination Summit!

Join the greatest minds in hepatology across the continent, including special guest speaker Francis S. Collins, MD, PhD, who is serving as a Special Projects Advisor to President Biden, for a game-changing two-day event on March 24 - 25 in Los Angeles — the 2023 North American Viral Hepatitis Elimination Summit.

With the goal of achieving viral hepatitis elimination and reducing liver complications including liver cancer among North Americans, AASLD has joined forces with the Canadian Association for the Study of the Liver (CASL) and the Mexican Association for the Study of the Liver (AMH) to foster collaboration, exchange ideas and increase knowledge translation.

You can register for this event alone or for the combo of the North American Viral Hepatitis Elimination Summit and NASH Cirrhosis Emerging Topic Conference.

When & Where

Date: Friday, March 24, 10:00 am - Saturday, March 25, 4:30 pm (EDT)
Location: JW Marriott Los Angeles L.A. LIVE | 900 West Olympic Boulevard | Los Angeles, CA 90015

Program Chairs

Special Guest Speaker

Learning Objectives

  1. Understand the status of national progress toward hepatitis elimination and the priorities to overcome gaps in hepatitis prevention, testing, care, and treatment in North America  
  2. Learn the strategies and technologies that improve hepatitis testing and linkage to care
  3. Call attention to priority populations and the novel approaches needed to reach goals for hepatitis elimination
  4. Characterize the risk population for liver cancer and strategies can reduce HCC incidence among persons with viral hepatitis
  5. Explore the “game changers” that have emerged in recent years and how they can be more broadly applied across countries in North America

Core Competencies:

  • Medical knowledge
  • Patient care
  • Practice-based learning and improvement
  • Systems-based learning

Target Audience:

  • Primary care
  • Public Health
  • Hepatologists and specialists
  • North American participation
  • Patient Advocates

Continuing Education:

Continuing Medical Education (CME): 9.50 AMA PRA Category 1 Credits™

ABIM Maintenance of Certification (MOC): 9.50 MOC Points

Travel Note

US residents: Please review the Real ID Act regarding boarding federally regulated commercial aircrafts. Due to circumstances resulting from the COVID-19 pandemic, the Department of Homeland Security has extended the REAL ID enforcement deadline to May 7, 2025. Depending on your state of residence, you may need to provide a second form of identification at the airport.

Schedule Note

Please note, all times in the agenda are listed in Pacific Daylight Time (PDT) as this is an in-person only event in Los Angeles, CA.

Agenda - March 24, 2023

7:00 am                      Breakfast

Session I: Reporting Card (Profiles of Elimination in N. America)

Moderators: John Ward and Robert Gish

8:00 am - 8:05 am      Introductory Remarks

8:05 am - 8:20 am      Topic #1: Canada (Public Health Agency of Canada)

                                    Speaker: Jill Norman

 

8:20 am - 8:35 am       Topic #2: Mexico (Mexico Health Ministry)

                                    Speaker: Alethse de la Torre Rosas

 

8:35 am - 8:50 am       Topic #3: U.S. (CDC, HHS)

                                    Speaker: Carolyn Wester

 

8:50 am - 9:05 am       Lancet Commission report/ US Update

                                    Speaker: Mark Sulkowksi (JHU)  

       

9:05 am - 9:25 am       Q/A

 

9:25 am - 9:45 am      Moderated Panel Discussion: Advocacy for Change 

                                   Action Hepatitis Canada

                                   Speaker: Jennifer Van Gennip

                                   Mexican Liver Foundation

                                    Speaker: Enrique Wolpert

                                    Representative of U.S. – ALF, HBV Foundation, GLI

                                    Speaker: Chari Cohen

 

9:45 am - 10:00 am   Break

Session II: Diagnostics

Moderators: Jordan Feld and Curtis Cooper

10:00 am - 10:20 am    Topic #1: One-time Screening for HBV (Include Implementation)

                                     Speaker: Erin Conners

 

10:20 am - 10:40 am    Topic #2: HCV Diagnosis – Matching the Test to the Patient (Include POC)

                                     Speaker: Lisa Barrett

 

10:40 am - 11:00 am    Topic #3: New HBV Diagnostics: What, How and Can We Do Better?

                                     Speaker: Carla Osiowy

 

11:00 am - 11:20 am     Topic #4: HDV: Who and How of Diagnosis

                                     Speaker: Theo Heller (NIDDK)

 

11:20 am - 11:35 am     Implementation of Screening for Viral Hepatitis (HBV, HCV, HDV): Strategies and Barriers
                                     Speaker: Robert Wong, MD, MS

 

11:35 am - 11:55 am     Panel Discussion/Q&A

11:55 am - 1:00 pm     Lunch

Session III: Priority Populations for HBV and HCV

Moderators: Ignacio Aiza and Althese de la Torre

1:00 pm - 1:15 pm      Topic #1: Pregnancy

                                   Speaker: Tatyana Kushner (Mount Sinai)

 

1:15 pm  - 1:30 pm      Topic #2: Indigenous People

                                    Speaker: Alexandra King (University of Saskatchewan)

 

1:30 pm - 1:45 pm        Topic #3: Newcomers/Refugees

                                     Speaker: Christina Greenaway

 

1:45 pm - 2:00 pm        Topic #4: Incarcerated

                                     Speaker: Nadine Kronfli (McGill University)

 

2:00 pm - 2:15 pm        Topic #5: Persons Who Use Drugs

                                     Speaker: Judith Feinberg (West Virginia University)

 

2:15 pm – 2:30 pm       Panel Discussion/Q&A

2:30 pm - 2:45 pm       Break

Session IV: HCC

Moderators: Norah Terrault and Sam So

2:45 pm - 3:00 pm       Topic #1: Linking VHE With Cancer Prevention

                                    Speaker: Jessica Petrick

 

3:00 pm - 3:15 pm       Topic #2: Challenges in Implementing HCC Surveillance

                                    Speaker: Amit Singal (UTSW)

 

3:15 pm - 3:30 pm       Topic #3: Can We Get Away From Imaging-based Surveillance?

                                    Speaker: Neehar Parikh (U Michigan)

 

3:30 pm - 3:45 pm       Topic #4: Is There a point Where Surveillance Can Be Stopped? Fibrosis Monitoring/Regression

                                    Speaker: Laura Cisneros

 

3:45 pm - 4:00 pm       Panel Discussion/Q&A

 

4:00 pm - 5:00 pm      HCV Elimination: A National Strategy

                                    Speaker: Francis Collins, MD, PhD

                                    Moderators: John Ward, MD and Norah Terrault, MD, MPH, FAASLD

5:00 pm - 6:30 pm      Light Reception

Agenda - March 25, 2023

7:00 am                       Breakfast

Session V: Building coalitions for action

Moderators: John Ward and Ignacio Aiza

8:00 am - 8:10 am       Topic #1 Louisiana Micro Elimination (Corrections)

                                    Speaker: Risha Irvin

 

8:10 am - 8:20 am       Topic #2 Getting HBV to the Forefront in California

                                    Speaker: Sam So (Stanford University)

 

8:20 am - 8:30 am       Topic #3 Supervised Injection Sites and HCV Elimination

                                    Speaker: Brian Conway

 

8:30 am - 8:40 am       Topic #4 DRUM & SASH project

                                    Speaker: Carrielynn Lund

 

8:40 am - 8:50 am       Topic #5 The Health Benefits and Cost of the U.S. National Hepatitis C Elimination Plan

                                    Speaker: Jagpreet Chhatwal

 

8:50 am - 9:00 am       Topic #6 Tijuana and Viral Hepatitis Treatment

                                    Speaker: Christian Ramers (UCSD)

 

9:00 am - 9:40 am     Panel Discussion/Q&A

 

9:40 am - 10:00 am   Break

Session VI: Game-Changers

Moderators: Norah Terrault and Jeff Lazarus

10:00 am - 10:20 am     Topic #1: Screening opportunities – lessons from COVID

                                      Speaker: John Ward

 

10:20 am - 10:40 am     Topic #2: Long acting injectables

                                      Speaker: Dave Thomas

 

10:40 am - 11:00 am     Topic #3: Therapeutic breakthroughs – focus on HBV

                                      Speaker: Ray Chung (MGH)

 

11:00 am - 11:20 am      Topic #4: Influencing National Policies – Mexico as an Example

                                       Speaker: David Kershenobich

 

11:20 am - 11:50 am      Panel Discussion/Q&A

 

11:50 am - 12:10 pm       Conference Summary and Wrap-Up

 

12:10 pm                         Adjourn

Boxed lunches will be available in the foyer.

Registration Rates: 2023 North American Viral Hepatitis Elimination Summit

General

Any physician, scientist, or researcher with doctoral-level training who is not employed by Industry (pharma/device/etc.)

Member Non-Member
Early Bird: On or Before February 23, 2023 $450 $670

Trainee & Associate

Any physician, scientist or researcher in a training program as certified by the director of their training program. This category also includes, but is not limited to, the degrees of MS, NP, PA, RN, and other related or comparable degrees.

Member Non-Member
On or After February 24, 2023 $220 $275

Student

Member Non-Member
On or After February 24, 2023 $110 $135

Industry

Any Industry (pharma/device/etc.) employee with or without medical training.

Industry
On or After February 24, 2023 $920

Patients, Patient Advocates and Caregivers

Patients, Patient Advocates, and Caregivers
Rate Complimentary

Registration Combo-Pricing for the North American Viral Hepatitis & NASH Cirrhosis Emerging Topic Conference

General

Any physician, scientist, or researcher with doctoral-level training who is not employed by Industry (pharma/device/etc.)

Member Non-Member
On or After February 24, 2023 $630 $940

Trainee & Associate

Any physician, scientist or researcher in a training program as certified by the director of their training program. This category also includes, but is not limited to, the degrees of MS, NP, PA, RN, and other related or comparable degrees.

Member Non-Member
On or After February 24, 2023 $310 $390

Student

Member Non-Member
On or After February 24, 2023 $150 $190

Industry

Any Industry (pharma/device/etc.) employee with or without medical training.

Industry
On or After February 24, 2023 $1,290

Patients, Patient Advocates and Caregivers

Patients, Patient Advocates, and Caregivers
Rate Complimentary

Registration Cancellation Policy

Requests for cancellations must be submitted in writing to meetings@aasld.org.

Cancellations received by Thursday, February 23, 2023 will be refunded in full.

Cancellations received between February 24 – March 6, 2023 will be subject to a $50.00 cancellation fee.

Cancellations received on or after March 7, 2023 are not eligible for a refund.

Housing

JW Marriott Los Angeles L.A. LIVE
900 W Olympic Blvd
Los Angeles, CA, 90015
Phone: 213-765-8600

Reserve your hotel today!

*When calling to make a reservation, please let the hotel representative know that you are attending the AASLD North American Viral Hepatitis Elimination Summit.

Single/Double $259 per night plus tax

Discounted rates are available until March 2, 2023.

Cancel your reservation for no charge until 72 hours prior to your arrival date.

Please note that the hotel will assess a fee of (1) night of your room charge (for the first night of your reservation) USD if you must cancel after this deadline.

Valet Daily: $53.90

Electric Car Charging Station Available

Los Angeles International Airport (LAX) - 17.2 miles from hotel

Hollywood Burbank Airport (BUR) - 16 miles from hotel